Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

28 October 2021
We are asking for your feedback on our proposal to remove the requirements for registered pharmacists to have two years of clinical practice, and to have relevant experience in a specific clinical or...
28 October 2021
Our governing council agreed that we should introduce a multi-year fees cycle and keep a flat-fee structure, rather than introduce differential fees, for registered pharmacy professionals at their...
28 October 2021
From 1 October 2021 the Botulinum Toxin and Cosmetic Fillers (Children) Act comes into force. We have worked with the Department of Health and Social Care (DHSC) to explain what this means for...
27 July 2021
This July we have marked the 10-year anniversary of pharmacy technician registration It became a legal requirement for pharmacy technicians to register with the GPhC from 1 July 2011 and pharmacy...
27 July 2021
This month we published our new five-year strategy for how we will manage concerns about pharmacy professionals Our governing council agreed the finalised strategy in their meeting in June, following...